|
AU2016219717A1
|
|
Treating dyspnea associated with acute heart failure with relaxin
|
|
PH12016500711A1
|
|
Method of treating dyspnea associated with acute heart failure
|
|
AU2013204203A1
|
|
Method of promoting wound healing
|
|
AU2013202952A1
|
|
Prediction and prevention of preeclampsia
|
|
AU2013201629A1
|
|
Treating dyspnea associated with acute heart failure with relaxin
|
|
AU2011204972A1
|
|
Methods and Compositions for Control of Fetal Growth via Modulation of Relaxin
|
|
WO2011112791A1
|
|
Modulating aquaporins with relaxin
|
|
TN2010000504A1
|
|
Treating dyspnea associated with acute heart failure with relaxin
|
|
BRPI0920897A2
|
|
prognosis and prevention of preeclampsia
|
|
CN106177914A
|
|
With the relaxin treatment dyspnea relevant to acute heart failure
|
|
MX336145B
|
|
Method of treating chronic heart failure.
|
|
CA2724542A1
|
|
Method of administering relaxin to reduce cervical dilation
|
|
NZ622598A
|
|
Treating acute decompensated heart failure with relaxin
|
|
CA2724308A1
|
|
Method of promoting wound healing
|
